ArticleJournal of assisted reproduction and genetics2012
Patient selection criteria for blastocyst transfers in extended embryo culture programs.
Article in Journal of assisted reproduction and genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Should the flexibility enabled by performing a day-4 embryo transfer remain as a valid option in the IVF laboratory? A systematic review and network meta-analysis.Journal of assisted reproduction and genetics · 2019Pooled it
- Article
- Effects of high-altitude hypoxia on embryonic developmental potential in women undergoing IVF/ICSI procedures.Archives of gynecology and obstetrics · 2023Article
- Estimating the causal effect of embryo transfer day on clinical in vitro fertilization outcomes using propensity score matching.BMC pregnancy and childbirth · 2021Article
- Cleavage Stage versus Blastocyst Stage Embryo Transfer in Oocyte Donation Cycles.Medicina (Kaunas, Lithuania) · 2019Article
- Protein expression in human cumulus cells as an indicator of blastocyst formation and pregnancy success.Journal of assisted reproduction and genetics · 2016Article
- Is the presence of an uncleaved embryo on day 3 a useful predictor of outcomes following day 5 transfer?Journal of assisted reproduction and genetics · 2015Article
- The importance of the cleavage stage morphology evaluation for blastocyst transfer in patients with good prognosis.Journal of assisted reproduction and genetics · 2014Article
- Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses.JBRA assisted reproduction · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo identify the correlation between different cycles, patient factors and blastocyst characteristics.
methodsThe study included 420 patients undergoing ICSI cycles and 2781 graded blastocysts, which took into account the blastocyst quality. The correlations between the blastocyst parameters and the patient and cycle characteristics were assessed.
resultsThe blastocyst development was negatively correlated with the maternal age, BMI and dose of FSH. The ICM was negatively correlated with the FSH dose, whereas the TE quality was influenced by the FSH dose, the maternal age and the number of retrieved oocytes. The embryo morphology on days two and three may predict the blastocyst developmental competence.
conclusionsOlder patients and patients with high BMI should not be included in extended embryo culture programmes. The extended culture may not favour embryos with poor morphology on days two and three of development. Additionally, a lower ovarian stimulation and decreased oocyte yields may lead to the development of high-quality blastocysts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.